SEMIRA: Tapering of Prednisone in Patients With Rheumatoid Arthritis Who Achieved Low Disease Activity or Remission With Tocilizumab

APLAR 2019: Brisbane, Australia; April 8-11, 2019; JCR: Kyoto, Japan; April 15-17, 2019
EULAR: Madrid, Spain; June 12-15, 2019
Prednisone tapering may be feasible in some RA patients with low disease activity or remission on tocilizumab, although continuous treatment provided superior disease control.
Format: Microsoft PowerPoint (.ppt)
File Size: 182 KB
Released: June 19, 2019


Provided by the Annenberg Center for Health Sciences at Eisenhower

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Supported by educational grants from
Gilead Sciences
Sanofi Genzyme and Regeneron Pharmaceuticals

Related Content

Stanley B. Cohen, MD, and Jonathan Kay, MD, provide CME/CE-certified analysis of 2019 APLAR, EULAR, and JCR as reported by Clinical Care Options (CCO)

Stanley B. Cohen, MD Jonathan Kay, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 19, 2019 Expiration: August 18, 2020

Leonard H. Calabrese, DO: expert viewpoint on data from 2019 APLAR, EULAR, and JCR including discussion of investigational and approved agents for RA

Leonard H. Calabrese, DO Released: July 23, 2019

Rheumatoid arthritis highlights from EULAR, APLAR, JCR 2019. Chosen by expert faculty and reported by Clinical Care Options.

Leonard H. Calabrese, DO Stanley B. Cohen, MD Paul Emery, MA, MD, FRCP Jonathan Kay, MD Released: July 3, 2019

Latest data on safety of upadacitinib from the SELECT phase III RA program in patients with RA. From EULAR 2019 as reported by Clinical Care Options.

Released: July 1, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?